Module

Pathobiology of Non-Hodgkin’s Lymphoma: Recent Advances

Source: Lymphoma Annual Update 2005

Pathobiology of Non-Hodgkin’s Lymphoma: Recent Advances

Program Director: Julie M. Vose, MD

Faculty:

Randy Gascoyne, MD, FRCPC

CREDIT INFORMATION

Release Date: 08/30/05

Expiration Date: 08/29/06

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.2 Nursing contact hours

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Review advances in gene expression profiling of various NHL subtypes.
Understand key intracellular pathways associated with NHL.
Describe genetic signatures associated with outcome and prognosis in NHL.

Content includes:

Pathobiology of Follicular Lymphoma
Cytogenetic profile of Follicular Lymphoma
The Role of Macrophages in Follicular Lymphoma
Extranodal MALT Lymphomas
FOXP Transcription Factors in MALT Lymphoma
Mantle Cell Lymphoma
Diffuse Large B-cell Lymphoma
Primary Mediastinal Large B-cell Lymphoma
Peripheral T-cell Lymphomas

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.